THROMBOTIC MICROANGIOPATHIES

Clinical trials for THROMBOTIC MICROANGIOPATHIES explained in plain language.

Never miss a new study

Get alerted when new THROMBOTIC MICROANGIOPATHIES trials appear

Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2 Terminated 1

New hope for rare blood disorder: experimental drug TGD001 enters human trials

Disease control Not yet recruiting

This early-phase trial tests a new drug called TGD001 in about 70 adults with acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP) or related blood clotting conditions. The main goal is to check the drug's safety and how the body processes it, while also l…

Matched conditions: THROMBOTIC MICROANGIOPATHIES

Phase: PHASE1, PHASE2 • Sponsor: TargED Biopharmaceuticals B.V. • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

THROMBOTIC MICROANGIOPATHIES

Get alerted when new THROMBOTIC MICROANGIOPATHIES trials appear

New hope for rare blood disorder: experimental drug TGD001 enters human trials